Drug-eluting balloon for instent restenosis

The Authors’ reply We thank Chen et al 1 for their feedback on our paper2 and we fully agree with most of their comments. Instent restenosis continues to be a problem even though the risk has been massively reduced by drug coating of stents.3 A significant proportion of patients had contraindications for drug-eluting stents (DES). Regarding the short-term and long-term follow-up data available for the PACCOCATH trial, we generally …